Phase I clinical study of peptide vaccine using Cancer-Testis antigen against advanced esophageal cancer
Phase 1
- Conditions
- Advanced esophageal squamous cell carcinoma refractory to standard therapeutic modality
- Registration Number
- JPRN-UMIN000004006
- Lead Sponsor
- Toho University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Pregnant woman (2)Lactating woman (3)Severe bleeding tendency (4)Uncontrolled infection (5)Concomitant treatment with steroids (6)patients who are judged inappropriate for the entry into study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the safety and adverse event.
- Secondary Outcome Measures
Name Time Method